Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B (Volume 392) (International Review of Cell and Molecular Biology, Volume 392)
Original price was: $345.36.$203.15Current price is: $203.15.
Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B (Volume 392) (International Review of Cell and Molecular Biology, Volume 392) | 9780443136559, Carolina, Reduzzi
Original price was: $345.36.$203.15Current price is: $203.15.
Adobooks Marketplace
Related Products
Author: Reduzzi, Carolina
Edition: 1
ISBN: 9780443136559
Release Date: 01-05-2025
Package Dimensions: 9.3 x 6.2 x 0.7 inches
Languages: English
Binding: hardcover
Number Of Pages: 208
Details: Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology. Provides the latest information on cancer research Offers outstanding and original reviews on a range of cancer research topics Serves as an indispensable reference for researchers and students alike
User Reviews
Be the first to review “Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B (Volume 392) (International Review of Cell and Molecular Biology, Volume 392)”
Vendor Information
- Store Name: Adobooks Marketplace
- Vendor: Adobooks Marketplace
- 4.71 rating from 7 reviews
Original price was: $345.36.$203.15Current price is: $203.15.
There are no reviews yet.